Summary.-Good immunoprotection was afforded by A9/SEWA somatic hybrid cells in the C3H mouse/C3H Py tumour system, confirming results previously obtained in the A.SW mouse/SEWA tumour system. However, in this study the immunogenicity decreased with increasing serial subculture of the hybrid line and concomitant chromosome loss.
WE HAVE previously shown the interesting occurrence of anti-tumour immunization with somatic hybrid cells (Favre, Carcassonne and Meyer, 1974a) . In these former experiments, we used the A.SW mouse/polyoma induced SEWA tumour system and protected by immunization with A9/SEWA hybrid cells. However, though we could demonstrate the presence of the tumour antigens characteristic of polyoma virus in these hybrid cells (Favre et al., 1974b) , we noticed that the transplantation antigen was gradually lost during in vitro passaging. This loss does not appear to be fortuitous since two different lines derived from the same hybrid parent displayed the same evolution. Evidently any clinical use of hybrid cells would presuppose the stability of such cells. We therefore describe here fturther experiments using the complementary H-2k system (C3H mouse/C3H Py solid tumour), where we tried to assess the protective effect of the A9/ SEWA hybrid line as a function of increasing subculture.
MATERIALS AND METHODS
Hybrid cells. The A9/SEWA hybrid cell line has been fully described elsewhere 14) (Harris et al., 1969) . It bears both the H-2s and H-2k histocompatibility loci. For this work, 2 series of A9/SEWA cultures, P and T, were used. The difference between these 2 series is that, on reception in our laboratory, the T series was already at a more advanced level of subculture than the P series.
Tumour cells-.The C3H-Py line was obtained by in vitro transformation of secondary C3H mouse embryo cultures by polyoma virus (Favre and Meyer, 1972) . The tumour challenge was effected by means of a dorsal, subcutaneous injection of 103 C3H-Py cells. Morphological and cytogenetic verification that some tumours observed in each group were C3H-Py sarcomata was carried out systematically.
Polyoma virus. The small plaque Toronto strain of polyoma virus grown in secondary mouse embryo cultures was used (Dulbecco, 1961 ).
Mice.-22 month old inbred C3H mice, bred in our laboratories, were used.
Immunization schedule.-Subcutaneous dorsal injections of 106 A9/SEWA hybrid cells were administered 21, 14 and 7 days before the tumour challenge. A control group received 3 injections of 107 PFU polyoma virus following the same time schedule.
Karyology.-The karyotypes were performed as previously described (Meyer, Berebbi and Klein, 1974) .
As is seen in Tz protection afforded line was very good. of confidence at the significant differenc between this grouj virus immunized gr and the group immiu hybrid T line and control group on the In the second e) we tried to assess Significant at 0 N.S. Non-significant ULTS able I, the immunoby the A91SEWA-P Using the interval e1% level, a highly we could be shown of the hybrid line as a function of the increasing number of times of subculture. By the 46th passage the A9/SEWA-P cells afforded less protection and practically none at all by the 61st passage.
) and the polyoma DISCUSSION DUp on the one hand We had previously reported that inized by cells of the (Favre et al., 1974) It has been hoped (Parkman, 1974) We wish to thank Mr J. Imbert for the statistical analysis, Mrs E. Mazzella and Mr V. Raineri for excellent technical assistance, and Mrs C. Lipcey for preparation of the manuscript in English.
